MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Ataxia: Genetics"

  • 2025 International Congress

    Neurological manifestations and genotypes of Gaucher disease type 3: MDSGene systematic review

    S. Schaake, T. Usnich, J. Boehm, N. Steffen, N. Schell, C. Krüger, T. Gül-Demirkale, N. Bahr, T. Kleinz, H. Madoev, B. Laabs, Z. Gan-Or, R. Alcalay, C. Marras, K. Lohmann, C. Klein, M. Rossi (Luebeck, Germany)

    Objective: To characterize the spectrum of neurological manifestations of Gaucher disease type 3 (GD3) and identify the most common GBA1 variants. Background: Gaucher disease is…
  • 2025 International Congress

    Clinical and Genetic Spectrum of Early-Onset Cerebellar Ataxia in India: A Tertiary Care Center Experience

    M. Raval, V. Holla, G. Arunachal, R. Raghavendra, N. Kamble, R. Yadav, P. Pal (Bengaluru, India)

    Objective: To characterize the genetic landscape of early-onset cerebellar ataxia excluding repeat expansion disorders. Background: Early-onset cerebellar ataxia (EOCA, age at onset ≤ 20 years) encompasses a diverse group of disorders with significant…
  • 2025 International Congress

    A case of ataxia and muscle stiffness in EEF2 gene mutation with associated anti-GAD antibodies

    H. Arrowood, J. Tamai (Poughkeepsie, USA)

    Objective: Here we present a case of ataxia and muscle stiffness in a person with variant EEF2 gene mutation with associated anti-GAD antibodies along with…
  • 2025 International Congress

    Spinocerebellar Ataxia Recessive Type 7 (SCAR7) in a Consanguineous Family: A Case Report

    T. Ozum, O. Akcin, C. Durmaz, G. Yalcin Cakmakli, B. Elibol (Ankara, Turkey)

    Objective: Spinocerebellar ataxia autosomal recessive type 7 (SCAR7) is a rare disorder caused by biallelic pathogenic variants in TPP1. It usually manifests in childhood or…
  • 2025 International Congress

    Genetic Ataxias in Argentina

    M. Rossi, M. Merello (Buenos Aires, Argentina)

    Objective: To determine the occurrence and frequency of genetic ataxias in Argentina. Background: Genetic ataxias comprise hundreds of disorders with significant phenotypic, genetic, and epidemiological…
  • 2025 International Congress

    The Role of Cognitive Impairment in the Effectiveness of Rehabilitation Training Programs for Parkinson’s Disease: A Review of Current Evidence

    A. Elsayed, Z. Hegazy, K. Ahmed, O. Sabry, S. Elsenbawy, G. Abozeid, M. M. Elsayed (Mansoura, Egypt)

    Objective: To examine the impact of cognitive impairment (CI) on the effectiveness of rehabilitation training programs in individuals with Parkinson’s disease (PD) and identify strategies…
  • 2025 International Congress

    Phenotypic Variability Across Four Generations in a Family with CACNA1A Mutation

    R. Usman, M. Moreno Escobar (Morgantown, USA)

    Objective: Our objective is to describe phenotypic variability across four generations in a family with a specific CACNA1A mutation. Background: CACNA1A is a gene located…
  • 2025 International Congress

    Peripheral neuropathy in Autosomal Recessive Spinocerebellar Ataxia due to ANO10 mutation – Expanding the phenotypic spectrum

    A. Vijayaraghavan (Thiruvananthapuram, India)

    Objective: SCAR10/ Adult-onset autosomal recessive cerebellar ataxia is an exceptionally rare form of ataxia, caused by mutations in the ANO10 gene and the specific genotype–phenotypecorrelation…
  • 2025 International Congress

    Genotype and age at onset drive vermis atrophy in CACNA1A and GAA-FGF14 related ataxias

    E. Indelicato, W. Nachbauer, M. Amprosi, E. Gizewski, S. Boesch, F. Krismer (Innsbruck, Austria)

    Objective: To assess cerebellar volumetry using a deep learning method in patients with non-polyglutamine CACNA1A- or GAA-FGF14-related disease. Background: Ion channel dysfunction is a recurring…
  • 2025 International Congress

    A Clinical Overlap Presentation of Episodic Ataxia Type 2 and Periodic Paralysis with a Novel Mutation in CACNA1A

    C. Vila, K. Minks, P. Morrison (Rochester, USA)

    Objective: To describe a case of episodic ataxia type 2 (EA2) with features of periodic paralysis (PP) associated with a novel mutation in CACNA1A. Background:…
  • 1
  • 2
  • 3
  • …
  • 32
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley